Veritex (VBTX) Director Trims Stake, Retains Majority Holding

Rhea-AI Filing Summary

Form 4 filing for Veritex Holdings, Inc. (VBTX) discloses that director Arcilia Acosta sold 7,279 shares of common stock on 29 Jul 2025 at a price of $32.14 per share (code “S”). Following the sale, Acosta’s directly held stake is 54,933 shares. No derivative securities were involved and there were no additional transactions reported. The filing was signed on 31 Jul 2025 by C. Malcolm Holland III under power of attorney.

The transaction modestly reduces the director’s direct ownership but leaves a sizable position. No 10b5-1 trading plan is indicated, suggesting the sale was discretionary. There is no mention of options exercises, purchases, or other insider activity.

Positive

• Director retains a substantial 54,933-share position, signalling continued commitment.

Negative

• Insider sale of 7,279 shares may be interpreted as reduced confidence in near-term upside.

Insights

Financial Analyst

TL;DR: Small insider sale; limited market impact.

The sale represents a routine disposition of roughly 12% of the director’s previously reported stake (based on post-sale holdings of 54,933 shares). The dollar value (~$234k) is minor relative to VBTX’s average daily trading volume, so liquidity impact is negligible. While insider selling can be perceived negatively, the remaining ownership indicates continued alignment with shareholders. Absence of a 10b5-1 plan could prompt questions on timing, but without accompanying negative news the filing is best viewed as neutral in valuation terms.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Acosta Arcilia

(Last) (First) (Middle)

8214 WESTCHESTER SUITE 800

(Street)

DALLAS TX 75225

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Veritex Holdings, Inc. [ VBTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/29/2025		S		7,279	D	$32.14	54,933	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ C. Malcolm Holland, III, by power of attorney	07/31/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Veritex (VBTX) shares did director Arcilia Acosta sell?

Acosta sold 7,279 common shares on 29 Jul 2025.

What price did the VBTX shares sell for?

The shares were sold at $32.14 per share.

How many VBTX shares does the director own after the transaction?

Post-sale, Acosta directly owns 54,933 shares.

Were any derivative securities involved in the filing?

No, Table II shows no derivative transactions for this filing.

Was the transaction executed under a Rule 10b5-1 plan?

The form does not indicate that the sale was made pursuant to a 10b5-1 trading plan.